Active ingredientMethsuximideCat. No. P-M089-001CAS 77-41-8Family · Pharmaceutical analytical standards
Methsuximide
An anticonvulsant of the succinimide family, approved in the United States in 1957 for absence (petit mal) seizures, particularly when they do not respond to other drugs. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?In the body it is converted into an active metabolite, N-desmethylmethsuximide, which stays in circulation more than ten times longer: about 28-38 hours versus 1-3 hours for the parent molecule.
Go to the active ingredient →Active ingredientMethsuximideCat. No. P-M089-001CAS 77-41-8
Isotopically labelledMethsuximide-d5Cat. No. P-M089-002CAS 1189980-63-9
Isotopically labelledNormesuximide-d5Cat. No. P-M089-003CAS 1185130-51-1
ImpurityNormesuximideCat. No. P-M089-004CAS 1497-17-2No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.